✦ LIBER ✦

The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma

✍ Scribed by Hajek, Roman; Siegel, David; Orlowski, Robert Z.; Ludwig, Heinz; Palumbo, Antonio; Dimopoulos, Meletios

Book ID: 121302649
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 292 KB
Volume: 55
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.797084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histone deacetylase inhibitors in multip

Histone deacetylase inhibitors in multiple myeloma

✍ Pratt, Guy 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 94 KB

Histone deacetylase inhibitors in the tr

Histone deacetylase inhibitors in the treatment for multiple myeloma

✍ Hideshima, Teru; Anderson, Kenneth C. 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 441 KB

Role of Histone Deacetylase Inhibitors i

Role of Histone Deacetylase Inhibitors in the Treatment of Lymphomas and Multiple Myeloma

✍ Zain, Jasmine 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 335 KB

A phase II multiple dose clinical trial

A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma

✍ Monica Galli; Silvia Salmoiraghi; Joseé Golay; Antonella Gozzini; Claudia Crippa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 105 KB

New Insights into the Treatment of Multi

New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors

✍ Cea, Michele; Cagnetta, Antonia; Gobbi, Marco; Patrone, Franco; G. Richardson, P 📂 Article 📅 2013 🏛 Bentham Science Publishers 🌐 English ⚖ 305 KB

Phase 2 trial of the histone deacetylase

Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

✍ Ruben Niesvizky; Scott Ely; Tomer Mark; Sangeeta Aggarwal; Janice L Gabrilove; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views